In this DNB//Back Bay Healthcare Capital Markets podcast episode, learn about the key considerations, mechanics and timelines of going public on a US exchange.
Topics in this podcast include:
- An overview of the decision-making process through execution for US-based and ex-US healthcare companies thinking about listing in the US
- Core considerations after deciding to pursue a US listing and how to prepare most effectively
- Building the “IPO advisory team”: types of advisors (legal, accounting, banking, IR firms, IP, etc.) and when to bring them in
- Key documents and associated timelines related to the SEC documentation as well as investor outreach
- What are the “don’ts” or mistakes companies make and how to avoid them
You can listen to previous episodes
here or submit your inquiries
here.
About our guests:
DNB//Back Bay is a committed partner throughout the healthcare development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on US and Nordic exchanges. Our team of more than 100 healthcare strategy and financial specialists spans the globe. Learn more about the DNB//Back Bay Partnership and read our disclaimers at
https://www.bblsa.com/dnb-back-bay-partnership.
Cooley is among the top law firms for healthcare, tech and life science IPOs on both the issuer-side and underwriter-side. Their team of 1,300 lawyers is spread across 19 offices worldwide.
What is Back Bay Life Science Report?
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.